Exhibit
10.1
SUBSCRIPTION
AGREEMENT
for
SMITHTOWN BANCORP,
INC.
A NEW YORK
CORPORATION
COMMON SHARES, PAR VALUE
$0.01 PER SHARE
THE COMMON
SHARES (“COMMON SHARES”) REFERRED TO HEREIN HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(“SECURITIES ACT”), AND ARE BEING OFFERED AND SOLD IN
RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF
THE SECURITIES ACT. THE OFFERING OF COMMON SHARES HAS NOT BEEN
REVIEWED OR APPROVED BY ANY FEDERAL OR STATE REGULATORY AUTHORITIES
AND IS NOT REGISTERED UNDER APPLICABLE FEDERAL OR STATE SECURITIES
LAWS.
A PURCHASER OF
THE COMMON SHARES MUST BE PREPARED TO BEAR THE ECONOMIC RISKS OF
THE INVESTMENT FOR AN INDEFINITE PERIOD OF TIME BECAUSE THE SHARES
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT AND ARE
RESTRICTED AS TO TRANSFERABILITY.
TABLE OF
CONTENTS
|
|
|
|
Page
|
|
|
|
|
|
|
|
Article
I
|
|
|
|
|
|
|
|
|
|
Purchase;
Closing
|
|
|
|
|
|
|
|
|
1.1
|
Purchase
|
|
1
|
|
1.2
|
Closing
|
|
3
|
|
|
|
|
|
|
|
Article
II
|
|
|
|
|
|
|
|
|
|
Representations and
Warranties
|
|
|
|
|
|
|
|
|
2.1
|
Disclosure
|
|
5
|
|
2.2
|
Representations
and Warranties of the Company
|
|
5
|
|
2.3
|
Representations
and Warranties of the Investor
|
|
10
|
|
|
|
|
|
|
|
Article
III
|
|
|
|
|
|
|
|
|
|
Covenants
|
|
|
|
|
|
|
|
|
3.1
|
Commercially
Reasonable Efforts
|
|
13
|
|
3.2
|
Expenses
|
|
13
|
|
3.3
|
Publicity
|
|
13
|
|
3.4
|
Further
Assurances
|
|
14
|
|
|
|
|
|
|
|
Article
IV
|
|
|
|
|
|
|
|
|
|
Additional Agreements of the
Investor
|
|
|
|
|
|
|
|
|
4.1
|
Transfer
Restrictions
|
|
14
|
|
4.2
|
Legend
|
|
15
|
|
4.3
|
Registration
Rights
|
|
16
|
|
|
|
|
|
|
|
Article
V
|
|
|
|
|
|
|
|
|
|
Miscellaneous
|
|
|
|
|
|
|
|
|
5.1
|
Survival
|
|
25
|
|
5.2
|
Indemnification
Generally
|
|
25
|
|
5.3
|
Interpretation
|
|
26
|
|
5.4
|
Amendment
|
|
26
|
|
5.5
|
Waiver of
Conditions
|
|
26
|
|
5.6
|
Counterparts
and Facsimile
|
|
26
|
|
5.7
|
Governing Law;
Submission to Jurisdiction, Etc
|
|
26
|
|
5.8
|
Notices
|
|
27
|
|
5.9
|
Entire
Agreement, Etc
|
|
27
|
|
5.10
|
Definitions of
“Subsidiary” and “Affiliate”
|
|
28
|
|
5.11
|
Severability
|
|
28
|
|
5.12
|
No Third Party
Beneficiaries
|
|
28
|
LIST OF
ANNEXES
|
Annex A
|
Form of Opinion
of Sullivan & Cromwell LLP
|
|
|
|
|
Annex B
|
Category of
Accredited Investor
|
|
|
|
|
Annex C
|
Federal Income
Tax Backup Withholding
|
|
|
|
|
Annex D
|
Individual
Investor Questionnaire
|
INDEX OF DEFINED
TERMS
|
|
|
Location of
Definition
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor
Material Adverse Effect
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shelf
Registration Statement
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subscription Agreement
, dated September 26, 2008 (together
with any attachments, annexes or exhibits hereto, collectively,
this “ Agreement ”), between Smithtown
Bancorp, Inc., a corporation organized under the laws of the State
of New York (the “ Company ”), and the
Investor listed on the signature page hereof (the “
Investor ”).
Recitals:
A. The Company . As of the date hereof, the Company has
(i) 20,000,000 authorized Common Shares, par value $0.01 per
share (the “ Common Shares ”), of which
9,834,477 shares are outstanding, and (ii) 100,000 authorized
Preferred Shares, par value $0.01 per share, of which no shares are
outstanding.
B. The Issuance . The Company intends to issue Common Shares in
a private placement (the “ Offering ”), and
the Investor intends to purchase from the Company the number of
Common Shares indicated on the signature page hereof (collectively,
the “ Purchased Securities ”). For purposes of
this Agreement, the term “ Transaction Documents
” refers collectively to this Agreement and any other
documents, agreements and instruments delivered in connection
herewith (including prior to the date hereof), in each case, as
amended, modified or supplemented from time to time in accordance
with their respective terms, including the Private Placement
Memorandum, dated September 26, 2008, provided to the Investor (the
“ Memorandum ”).
NOW, THEREFORE, in consideration of the premises, and of the
representations, warranties, covenants and agreements set forth
herein, the parties agree as follows:
Article
I
Purchase;
Closing
(a) Subscription . The Investor hereby irrevocably subscribes to
purchase the number of Purchased Securities indicated on the
signature page hereof for a period of 30 days from the Subscription
Date (as hereinafter defined), in accordance with the terms of this
Subscription Agreement (the “ Purchase ”). To
effect such subscription, the Investor shall deliver an executed
counterpart of this Agreement, including all Annexes hereto, to the
Company or its authorized representative.
(b) Payment . Together with delivery of an executed
counterpart of this Agreement, including all Annexes hereto, the
Investor shall deliver and pay in full the aggregate purchase price
for the Purchased Securities specified on the signature page hereof
(the “ Payment ”) in United States funds, to
Wilmington Trust Company, the Company’s escrow agent, in the
form of (1) a certified or bank cashier’s check, in
immediately available funds, made payable to “Wilmington
Trust Company, as Escrow Agent for Smithtown Bancorp, Inc., Account
#089834-000, Attention David Young” or (2) an
immediately available wire transfer to the following account:
Wilmington Trust Company, ABA #031100092, Credit: Smithtown
Bancorp, Inc., Escrow Account #089834-000, Attention David
Young.
(c) Acceptance . This Agreement shall be effective immediately
upon acceptance by the Company of the Investor’s executed
counterpart of this Agreement and shall thereupon be binding upon
the Company. Such acceptance by the Company shall be evidenced only
by counter-execution and delivery of this Agreement by the Company,
and the Company shall have no obligation hereunder until the
Company shall have executed and delivered to the Investor an
executed counterpart of this Agreement. The Investor acknowledges
and agrees that the Company, in its sole discretion, reserves the
right to accept or reject the Purchase, in whole or in part;
provided, however , that if the Company rejects the
Purchase by notice to the Investor, such rejection shall serve as a
termination of this Agreement, and the Investor shall have no
further rights or obligations under this Agreement (but any other
Transaction Document that expires by its terms as of a different
date shall remain in full force and effect).
|
|
|
This Agreement
may not be terminated by the Company unless, before the Closing
occurs, the Company determines in good faith that the conditions to
the Closing set forth in Section 1.2(d) will not be satisfied
within 10 days of the date of the Company’s acceptance of the
Investor’s subscription by counter-execution and delivery of
this Agreement by the Company. The Company shall deliver notice of
such termination to the Investor promptly upon making such
determination, and such termination shall have the effect of
terminating this Agreement, effective as of the date such notice is
received by the Investor in accordance with Section 5.8.
Subject to the foregoing, the Company agrees to use its
commercially reasonable efforts to consummate the Closing on the
Closing Date (as hereinafter defined) or as soon as practicable
thereafter.
|
|
|
|
This Agreement
may not be terminated by the Investor at any time following the
Investor’s delivery of an executed counterpart of this
Agreement to the Company (even if the Company has not yet accepted
or rejected the Purchase); provided, however ,
that, before the Closing has occurred, the Investor
may withdraw its subscription by delivering notice of such
withdrawal to the Company after a period of 15 days after the date
(the “ Subscription Date ”) that is the later
of (x) the first date the Investor delivers an executed
counterpart of this Agreement, including all Annexes hereto, to the
Company or its authorized representative and (y) the first
date the Investor delivers the Payment in accordance with
Section 1.1(b). Such withdrawal shall have the effect of
terminating this Agreement, effective as of the date such notice is
received by the Company in accordance with
Section 5.8.
|
|
|
|
Notwithstanding
the foregoing, this Agreement may be terminated by either the
Company or the Investor upon written notice to the other if the
Closing shall not have occurred on or before October 3,
2008.
|
|
|
|
In the event of
termination of this Agreement as provided in this
Section 1.1(d), (A) this Agreement shall forthwith become
void, and there shall be no liability on the part of either party
hereto, except that nothing herein shall relieve either party from
liability for any willful breach of this Agreement, and
(B) the Company shall promptly instruct its escrow agent to
return any previously delivered Payment to the Investor, without
interest.
|
(a) On the terms and subject to the conditions set
forth in this Agreement, the closing of the Purchase (the “
Closing ”) will take place at the offices of
Sullivan & Cromwell LLP, 125 Broad Street, New York, New York
10004, at 10:00 a.m., New York City time, on September 29, 2008 or
as soon as practicable thereafter, or at such other place, time and
date as shall be agreed between the Company and the Investor. The
time and date on which the Closing occurs is referred to in this
Agreement as the “ Closing Date .”
(b) At the Closing, the Company will deliver to the
Investor the Purchased Securities, as evidenced by one or more
certificates dated the Closing Date and bearing appropriate legends
as hereinafter provided for, registered on the books and records of
the Company in such Investor’s name.
(c) The obligation of the Investor to consummate
the Closing is also subject to the fulfillment (or waiver by the
Investor) at or prior to the Closing of each of the following
conditions:
|
|
|
(A) the
representations and warranties of the Company set forth in this
Agreement shall be true and correct as though made on and as of the
Closing Date (other than representations and warranties that by
their terms speak as of another date, which representations and
warranties shall be true and correct as of such date), except to
the extent that the failure of such representations and warranties
to be so true and correct (without giving effect to any qualifiers
or exceptions relating to materiality or Material Adverse Effect
(as hereinafter defined)), individually or in the aggregate, does
not have and would not reasonably be expected to have a Material
Adverse Effect and (B) the Company shall have performed in all
material respects all obligations required to be performed by it
under this Agreement at or prior to the Closing;
|
|
|
|
the Investor
shall have received from Sullivan & Cromwell LLP a legal
opinion in the form attached hereto as Annex A
, addressed to the Investor, dated as of the Closing Date;
and
|
|
|
|
the Investor
shall have received a certificate dated as of the Closing Date
signed on behalf of the Company by a senior officer of the Company
certifying compliance with Section 1.2(c)(1).
|
(d) The obligation of the Company to consummate the
Closing is also subject to the fulfillment (or waiver by the
Company) at or prior to the Closing of each of the following
conditions:
|
|
|
(A) the
representations and warranties of the Investor set forth in this
Agreement shall be true and correct as though made on and as of the
Closing Date (other than representations and warranties that by
their terms speak as of another date, which representations and
warranties shall be true and correct as of such date), except to
the extent that the failure of such representations and warranties
to be so true and correct (without giving effect to any qualifiers
or exceptions relating to materiality or Material Adverse Effect
(as hereinafter defined)), individually or in the aggregate, does
not have and would not reasonably be expected to have a Material
Adverse Effect and (B) the Investor shall have performed in
all material respects all obligations required to be performed by
it under this Agreement at or prior to the Closing;
|
|
|
|
the Company
shall have received from Sullivan & Cromwell LLP a legal
opinion substantially in the form attached hereto as Annex
A , addressed to the Company, dated as of the Closing
Date; and
|
|
|
|
the Company
shall have received a certificate dated as of the Closing Date
signed by the Investor or an authorized representative of the
Investor certifying compliance with
Section 1.2(d)(1).
|
Article
II
Representations and
Warranties
(a) “ Material Adverse Effect
” means a material adverse effect on (1) the business,
results of operation or financial condition of the Company and its
subsidiaries taken as a whole; provided that Material
Adverse Effect shall not be deemed to include the effects of
(A) any facts, circumstances, events, changes or occurrences
generally affecting businesses and industries in which the Company
operates, companies engaged in such businesses or industries or the
economy, or the financial or securities markets and credit markets
in the United States or elsewhere in the world, including effects
on such businesses, industries, economy or markets resulting from
any regulatory or political conditions or developments, or any
outbreak or escalation of hostilities, declared or undeclared acts
of war, terrorism, or work stoppages, (B) changes or proposed
changes in generally accepted accounting principles in the United
States (“ GAAP ”) or regulatory accounting
requirements applicable to depository institutions and their
holding companies generally (or authoritative interpretations
thereof), (C) changes or proposed changes in banking and other
laws of general applicability or related policies or
interpretations of all United States governmental or regulatory
authorities (collectively, “ Governmental Entities
”), or (D) changes in the market price or trading volume
of Common Shares (it being understood and agreed that the exception
set forth in this clause (D) does not apply to the underlying
reason giving rise to or contributing to any such change), or
(2) the ability of the Company timely to consummate the
Purchase and the other transactions contemplated by the Transaction
Documents.
(b) “ Previously Disclosed ”
means (1) information contained in the Company’s Annual
Report on Form 10-K for the fiscal year ended
December 31, 2007, or its other reports and forms filed with
the Securities and Exchange Commission (the “ SEC
”) under Sections 13(a), 14(a) or 15(d) of the
Securities Exchange Act of 1934 (the “ Exchange Act
”) on or after January 1, 2008 (the “ SEC
Reports ”) and prior to the execution and delivery of
this Agreement, and (2) information contained in the
Memorandum.
(c) Each party acknowledges that it is not relying
upon any representation or warranty not set forth in the
Transaction Documents. The Investor acknowledges that it has
conducted a review and analysis of the business, assets, condition,
operations and prospects of the Company and its subsidiaries,
together with the representations and warranties of the Company set
forth in the Transaction Documents, that the Investor considers
sufficient for purposes of the Purchase.
2.2 Representations and Warranties of the
Company . Except as
Previously Disclosed, the Company represents and warrants to the
Investor that as of the date hereof and the Closing Date (or such
other date specified herein):
(a) Organization, Authority and Significant
Subsidiaries . The
Company has been duly incorporated and is validly existing as a
corporation in good standing under the laws of the State of New
York, with corporate power and authority to own its properties and
conduct its business in all material respects as currently
conducted, and, except as has not had or would not reasonably be
expected to have a Material Adverse Effect, has been duly qualified
as a foreign corporation for the transaction of business and is in
good standing under the laws of each other jurisdiction in which it
owns or leases properties or conducts any business so as to require
such qualification; and each Subsidiary (as defined in
Section 5.10(a)) of the Company that is a “significant
subsidiary” within the meaning of Rule 1-01(w) of
Regulation S-X under the Securities Act of 1933, as amended
(the “ Securities Act ”) (each, a “
Significant Subsidiary ” and, collectively, the
“ Significant Subsidiaries ”) has been duly
organized and is validly existing in good standing under the laws
of its jurisdiction of organization. The Company’s principal
depository institution Subsidiary is duly organized and validly
existing as a New York State chartered bank, and its deposit
accounts are insured up to applicable limits by the Federal Deposit
Insurance Corporation (the “ FDIC
”).
|
|
|
As of the date
hereof, the authorized and outstanding capital stock of the Company
is as set forth in Recital A.
|
|
|
|
All of the
outstanding shares of capital stock of the Company have been duly
and validly authorized and issued and are fully paid and
non-assessable and were not issued in violation of any preemptive
rights, resale rights, rights of first refusal or similar
rights.
|
|
|
|
All of the
outstanding shares of capital stock of each Significant Subsidiary
have been duly and validly authorized and issued, are fully paid
and non-assessable and were not issued in violation of any
preemptive rights, resale rights, rights of first refusal or
similar rights, and are owned directly or indirectly by the
Company, free and clear of all security interests, liens,
encumbrances, equities or claims.
|
|
|
|
Except for the
Rights (as hereinafter defined) issued pursuant to the Rights
Agreement (as hereinafter defined) and awards of restricted Common
Shares pursuant to the Company’s equity compensation and/or
employee stock purchase plans, there are no options, warrants or
other rights, agreements, arrangements or commitments to which the
Company is a party or by which the Company is bound relating to the
issued or unissued Common Shares of the Company. For purposes of
this Agreement, “ Rights ” means the rights to
purchase Common Shares of the Company issued pursuant to the Rights
Agreement, and “ Rights Agreement ” means the
Shareholder Protection Rights Agreement, dated as of September 23,
1997 and last amended as of February 6, 2008, by and between the
Company and Mellon Investor Services LLC, setting forth the
rights of the holders of Rights.
|
(c) The Purchased Securities . The Purchased Securities will be, as of the
Closing Date, duly authorized by all necessary corporate action on
the part of the Company and, when issued and delivered as provided
in this Agreement, will be duly and validly issued, fully paid and
non-assessable, and the issuance thereof will not be subject to any
preemptive or similar rights.
(d) Authorization and Enforceability of Transaction
Documents .
|
|
|
The Company has
the corporate power and authority to execute and deliver the
Transaction Documents to which it is a party and to carry out its
obligations hereunder and thereunder (which includes the issuance
of the Purchased Securities). The execution, delivery and
performance by the Company of the Transaction Documents to which it
is a party and the consummation of the transactions contemplated
hereby and thereby have been duly authorized by all necessary
corporate action on the part of the Company and its shareholders,
and no further approval or authorization is required on the part of
the Company or its shareholders. The Transaction Documents to which
the Company is a party are or will be valid and binding obligations
of the Company enforceable against the Company in accordance with
their respective terms, except as the same may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium or
similar laws affecting the enforcement of creditors’ rights
generally and general equitable principles, regardless of whether
such enforceability is considered in a proceeding at law or in
equity (“ Bankruptcy Exceptions ”).
|
|
|
|
The execution,
delivery and performance by the Company of the Transaction
Documents to which it is a party, the consummation of the
transactions contemplated hereby and thereby and compliance by the
Company with any of the provisions hereof and thereof, will not
violate, conflict with, or result in a breach of any provision of,
or constitute a default (or an event which, with notice or lapse of
time or both, would constitute a default) under, result in the
termination of or accelerate the performance required by, or result
in a right of termination or acceleration of, or result in the
creation of, any lien, security interest, charge or encumbrance
upon any of the properties or assets of the Company or any
Significant Subsidiary under any of the terms, conditions or
provisions of (A) the certificate of incorporation, by-laws or
other organizational document of the Company or any Significant
Subsidiary or (B) any note, bond, mortgage, indenture, deed of
trust, license, lease, agreement or other instrument or obligation
to which the Company or any Significant Subsidiary is a party or by
which it or any Significant Subsidiary may be bound, or to which
the Company or any Significant Subsidiary or any of the properties
or assets of the Company or any Significant Subsidiary may be
subject, or (C) subject to compliance with the statutes and
regulations referred to in Section 2.2(d)(3), violate any
statute, rule or regulation or any judgment, ruling, order, writ,
injunction or decree applicable to the Company or any Significant
Subsidiary or any of their respective properties or assets except,
in the case of clauses (B) and (C), for those occurrences
that, individually or in the aggregate, have not had and would not
reasonably be expected to have a Material Adverse
Effect.
|
|
|
|
Other than in
connection or in compliance with the provisions of the Securities
Act and the securities or “blue sky” laws of the
various states, to the Company’s Knowledge without inquiry,
no notice to, filing with, exemption or review by, or
authorization, consent or approval of, any Governmental Entity is
required to be made or obtained by the Company in connection with
the Purchase and the other transactions contemplated by the
Transaction Documents.
|
(e) Company Financial Statements
. The consolidated financial
statements of the Company and its subsidiaries (including the
related notes and supporting schedules) contained in the SEC
Reports present fairly in all material respects the consolidated
financial position of the Company and its consolidated subsidiaries
as of the dates indicated therein and the consolidated results of
their operations for the periods specified therein; and except as
stated therein, such financial statements were prepared in
conformity with GAAP applied on a consistent basis.
(f) No Material Adverse Effect
. Since June 30, 2008, no fact,
circumstance, event, change, occurrence, condition or development
has occurred that, individually or in the aggregate, has had or
would reasonably be expected to have a Material Adverse
Effect.
(g) Proceedings . As of the date of this Agreement, there is no
litigation or similar proceeding or governmental proceeding pending
or, to the Company’s Knowledge, threatened to which the
Company or any of its subsidiaries is a party or of which any
property of the Company or any of its subsidiaries is the subject
that the Company’s management believes, individually or in
the aggregate, has had or would reasonably be expected to have a
Material Adverse Effect.
(h) Compliance with Laws; Permits
.
|
|
|
The Company is
a bank holding company registered under the Bank Holding Company
Act of 1956 (the “ BHC Act ”); the Company and
each of its subsidiaries have conducted their businesses in
compliance with all applicable federal, state and foreign laws,
orders, judgments, decrees, rules, regulations and applicable stock
exchange requirements, including all laws and regulations
restricting activities of bank holding companies and banking
organizations, except for any noncompliance that, individually or
in the aggregate, has not had and would not be reasonably expected
to have a Material Adverse Effect.
|
|
|
|
The Company and
each Subsidiary have all permits, licenses, authorizations, orders
and approvals of, and have made all filings, applications and
registrations with, any Governmental Entities that are required in
order to carry on their business as presently conducted, except
where the failure to have such permits, licenses, authorizations,
orders and approvals or the failure to make such filings,
applications and registrations, individually or in the aggregate,
have not had and would not reasonably be expected to have a
Material Adverse Effect; and all such permits, licenses,
certificates of authority, orders and approvals are in full force
and effect and, to the Knowledge of the Company without inquiry, no
suspension or cancellation of any of them is threatened, and all
such filings, applications and registrations are current, except
where such absences, suspensions or cancellations, individually or
in the aggregate, have not had or would not reasonably be expected
to have a Material Adverse Effect.
|
|
|
|
Since
December 31, 2006, the Company has timely filed all documents
required to be filed with the SEC pursuant to Sections 13(a),
14(a) and 15(d) of the Exchange Act.
|
|
|
|
Since
December 31, 2006, the Company and each Subsidiary have filed
all material reports, registrations and statements, together with
any required amendments thereto, that it was required to file with
the Board of Governors of the Federal Reserve System (the “
Federal Reserve ”), the FDIC, the New York State
Banking Department and any other applicable federal or state
securities or banking authorities, except where the failure to file
any such report, registration or statement, individually or in the
aggregate, has not had and would not reasonably be expected to have
a Material Adverse Effect. As of their respective dates, each of
the foregoing reports complied with all applicable rules and
regulations promulgated by the Federal Reserve, the FDIC, the New
York State Banking Department and any other applicable foreign,
federal or state securities or banking authorities, as the case may
be, except for any failures that, individually or in the aggregate,
have not had and would not reasonably be expected to have a
Material Adverse Effect.
|
(j) Memorandum . The Memorandum does not contain an untrue
statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made,
not misleading.
(k) No General Solicitation or General
Advertising . Neither the
Company nor any person acting on its behalf has engaged or will
engage in any form of general solicitation or general advertising
(within the meaning of Regulation D under the Securities Act)
in connection with any offer or sale of the Purchased
Securities.
(l) No Integration . The Company has not, directly or indirectly,
solicited any offer to buy or offer to sell any Common Shares in a
manner that would require the registration of the Purchased
Securities pursuant to the Securities Act and has no present
intention to solicit any offer to buy or offer to sell any
Purchased Securities or any other securities of the Company other
than pursuant to (1) this form of Subscription Agreement,
(2) pursuant to a registered public offering of the Purchased
Securities and other Common Shares offered and sold in the Offering
as contemplated by this form of Subscription Agreement or
(3) pursuant to the Company’s equity compensation and/or
employee stock purchase plans.
2.3 Representations and Warranties of the
Investor . The Investor
hereby represents and warrants to the Company that as of the date
hereof and the Closing Date:
(a) Organization and Authority
. The Investor (1) has been
duly organized and is validly existing in good standing under the
laws of the jurisdiction of its organization, with the requisite
power and authority to own its properties and conduct its business
as currently conducted or (2) is a natural person.
(b) Authorization and Enforceability of Transaction
Documents .
|
|
|
The Investor
has the requisite power and authority to execute and deliver the
Transaction Documents to which it is a party and to carry out its
obligations hereunder and thereunder. The execution, delivery and
performance by the Investor of the Transaction Documents to which
it is a party and the consummation of the transactions contemplated
hereby and thereby have been duly authorized by all necessary
action on the part of the Investor, and no further approval or
authorization is required on the part of the Investor. The
Transaction Documents to which the Investor is a party are or will
be valid and binding obligations of the Investor enforceable
against the Investor in accordance with their respective terms,
except as the same may be limited by Bankruptcy
Exceptions.
|
|
|
|
The execution,
delivery and performance by the Investor of the Transaction
Documents to which it is a party, the consummation of the
transactions contemplated hereby and thereby and compliance by the
Investor with any of the provisions hereof and thereof, will not
(A) violate, conflict with, or result in a breach of any
provision of or constitute a default (or an event which, with
notice or lapse of time or both, would constitute a default) under,
or result in the termination of, accelerate the performance
required by, result in a right of termination or acceleration of or
result in the creation of, any lien, security interest, charge or
encumbrance upon any of the properties or assets of such Investor
under any of the terms, conditions or provisions of (i) its
organizational documents or (ii) any note, bond, mortgage,
indenture, deed of trust, license, lease, agreement or other
instrument or obligation to which the Investor is a party or by
which it may be bound, or to which the Investor or any of the
properties or assets of the Investor may be subject, or
(B) subject to compliance with the statutes and regulations
referred to in Section 2.3(b)(3), violate any statute, rule or
regulation or any judgment, ruling, order, writ, injunction or
decree applicable to the Investor or any of its properties or
assets except, in the case of clauses (A)(ii) and (B), for
those occurrences that, individually or in the aggregate, have not
had and would not reasonably be expected to have an Investor
Material Adverse Effect. “ Investor Material Adverse
Effect ” means a material adverse effect on the ability
of the Investor timely to consummate the Purchase and the other
transactions contemplated by this Agreement.
|
|
|
|
Other than in
connection or in compliance with the provisions of the Securities
Act and the securities or “blue sky” laws of the
various states, to the Investor’s Knowledge without inquiry,
no notice to, filing with, exemption or review by, or
authorization, consent or approval of, any Governmental Entity is
required to be made or obtained by the Investor in connection
with
|
|